Mirum Pharmaceuticals (MIRM) Tax Provisions (2019 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly Tax Provisions of $475000.0 in Q1 2026, down 38.07% quarter-over-quarter from $767000.0 in Q4 2025, and down 53.84% on a YoY basis from $1.0 million in Q1 2025.
Mirum Pharmaceuticals (MIRM) Tax Provisions (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Tax Provisions history runs 8 years deep, the most recent figure standing at $475000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 53.84% year-over-year to $475000.0; the TTM figure through Mar 2026 stood at $1.4 million (down 3.69% YoY), while the FY2025 annual figure was $1.9 million, up 87.96% from the prior year.
- Tax Provisions was $475000.0 for Q1 2026 at Mirum Pharmaceuticals, down from $767000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.0 million in Q1 2025 to a low of -$6.6 million in Q2 2022.
- Historically, Tax Provisions has averaged -$116117.6 across 5 years, with a median of $249000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions slumped 59827.27% in 2022, then soared 1815.38% in 2023.
- A 5-year view of Tax Provisions shows it stood at $140000.0 in 2022, then surged by 60.71% to $225000.0 in 2023, then sank by 356.0% to -$576000.0 in 2024, then soared by 233.16% to $767000.0 in 2025, then tumbled by 38.07% to $475000.0 in 2026.
- The last three Tax Provisions figures came in at $475000.0 (Q1 2026), $767000.0 (Q4 2025), and -$262000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn | 475,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 475,000.00 |
| Dec 31, 2025 | 767,000.00 |
| Sep 30, 2025 | -262,000.00 |
| Jun 30, 2025 | 402,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -576,000.00 |
| Sep 30, 2024 | 347,000.00 |
| Jun 30, 2024 | 635,000.00 |
| Mar 31, 2024 | 624,000.00 |
| Dec 31, 2023 | 225,000.00 |
| Sep 30, 2023 | 249,000.00 |
| Jun 30, 2023 | 316,000.00 |
| Mar 31, 2023 | 201,000.00 |
| Dec 31, 2022 | 140,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | -6.57 Mn |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 11,000.00 |